Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
‘Industry Failing On Evidence Generation,’ US FDA’s Califf Says Of Accelerated Approvals
Oct 18 2022
•
By
Francesca Bruce
Reform of the accelerated approval pathway will be “considered later this year in one way or another," said FDA chief Califf • Source: Screenshot
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United States
More from Conferences